significantly downregulated the protein and mRNA levels of Epidermal Growth Factor Receptor (EGFR), VEGF and the Cluster of Differentiation 34 (CD34) transmembrane cell-cell adhesion factor in tumour-bearing BALB/c mice, thereby inhibiting tumour growth [96]. This evidence concerns the gene CD34 and neoplasm.